<DOC>
	<DOCNO>NCT02015923</DOCNO>
	<brief_summary>Main outcome : Assess impact cancer-related survival 2 year patient unresectable metastatic colorectal cancer treat chemotherapy alone versus surgery follow chemotherapy . To assess overall survival . To evaluate postoperative morbidity mortality patient treat resection primary tumor . Assess complication meed surgery patient treat systemic chemotherapy course disease . Identify describe complication relate chemotherapy toxicity short medium term systemic treatment . Assessing quality life questionnaire QLQ-C30 QLQ-CR29 . To study prognostic survival factor . Method : multicenter randomize clinical trail ( 22 hospital ) . Two parallel group evaluate two therapeutic strategy colorectal cancer metastasis unresectable stage IV : chemotherapy alone versus primary tumor resection plus chemotherapy . Subjects : patient unresectable nonmetastatic colorectal cancer . Hypothesis : Surgical resection primary tumor stage IV colorectal patient unresectable synchronous metastasis increase 14 % overall survival compare patient receive systemic treatment chemotherapy without resection primary tumor ( survival 34 % vs 20 % ) .</brief_summary>
	<brief_title>Resection v Resection Primary Colorectal Cancer With Unresectable Metastases</brief_title>
	<detailed_description>Intervention : Arm B ( control ) : chemotherapy alone , regimen accord center . Arm A ( experimental ) : surgery ( complete tumoral resection ; R0 ) follow chemotherapy , regimen accord center . Statistical Analysis : A power analysis show assure significance level 0,05 beta error 0.20 . 168 patient necessary arm . It estimate loss rate 10 % . Differences group analyze , U , X2 , exact test survival assess accord Kaplan Meier method . Evaluation safety trial make middle study statistically</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>colorectal cancer 12 cm anal verge unresectable synchronous metastasis contraindication chemotherapy absence peritoneal carcinomatosis , central nervous system bone metastasis . performance status ECOG â‰¤ 2 ( Eastern Cooperative Oncology Group ) uncontrolled concomitant medical condition may compromise chemotherapy significant symptomatic cardiac disease pregnancy breastfeed Cases rectal tumours 12cm anal verge , locally advanced tumour invade blood vessel , nerve bone . Multiple bone metastasis central nervous system metastasis Other neoplastic disease 5 previous year , except squamous basal cell skin carcinoma cervical `` situ '' carcinoma Significant heart disease ( chronic congestive heart failure , symptomatic coronary disease ) myocardial infarction previous 6 month Peripheral neuropathy Patients give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Colonic cancer</keyword>
	<keyword>Metastasis</keyword>
</DOC>